Atlas Trials

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT03467932 · COMPLETED

Trial details

NCT number
NCT03467932
Sponsor
Oramed, Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
T2DM (Type 2 Diabetes Mellitus)
Start date
2018-05-29
Primary completion
2019-10-21
Enrollment
373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.